相关实验视频
Updated: Jun 27, 2025

14:49
Conducting Respiratory Oscillometry in an Outpatient Setting
Published on: April 8, 2022
7.1K
改善儿童喘管理的目标监测工具
Phillip L W Au-Doung1, Jason C H Chan1, Oliver Y H Kui1
1School of Pharmacy, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong SAR, China.
Respiratory research
|May 3, 2024
概括
客观的工具可以改善儿童喘监测,帮助早期发现和有效治疗. 这篇评论探讨了螺旋计,FeNO和EMDs,以更好地治疗儿科喘.
科学领域:
- 儿科肺病学 儿科肺病学
- 呼吸系统医学 呼吸系统医学
- 临床研究 临床研究
背景情况:
- 儿童喘仍然是一个重要的全球健康问题,死亡率高.
- 有效控制喘对于预防可能致命的恶化至关重要.
- 目前的主观监测方法由于依赖于自我感知而缺乏可靠性.
研究的目的:
- 在全球范围内审查儿童喘的流行率和严重程度.
- 评估儿童喘中新兴客观监测工具的有效性.
- 为在临床实践中标准化客观监测提供见解.
主要方法:
- 从2016-2023年对客观儿科喘监测工具的出版物的系统审查.
- 包括对螺旋计,微分呼出氧化 (FeNO),超响应性测试和电子监测设备 (EMD) 的研究.
- 分析的重点是每个工具的有效性,优势和局限性.
主要成果:
- 像螺旋计,FeNO和EMD等客观工具显示出更准确的喘评估的希望.
- 这些工具可以帮助检测疾病进展和治疗反应.
- 缺乏共识目前阻碍了这些客观方法的标准化.
结论:
- 客观的监测工具为改善儿童喘管理提供了巨大的潜力.
- 需要进一步的研究,以建立标准化的协议,用于他们的临床使用.
- 临床医生可以从了解各种客观工具的能力中获益,以改善患者护理.
相关概念视频
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-IV: Nursing Management
3.0K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.0K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Inhaled Medications
255
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
255
COPD: Management Using Bronchodilators and Corticosteroids
198
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
198
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
279
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
279

